340 related articles for article (PubMed ID: 28356382)
1. Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.
Martin JC; Wolk K; Bériou G; Abidi A; Witte-Händel E; Louvet C; Kokolakis G; Drujont L; Dumoutier L; Renauld JC; Sabat R; Josien R
J Immunol; 2017 May; 198(9):3671-3678. PubMed ID: 28356382
[TBL] [Abstract][Full Text] [Related]
2. Regulation of IL-22BP in psoriasis.
Voglis S; Moos S; Kloos L; Wanke F; Zayoud M; Pelczar P; Giannou AD; Pezer S; Albers M; Luessi F; Huber S; Schäkel K; Kurschus FC
Sci Rep; 2018 Mar; 8(1):5085. PubMed ID: 29572462
[TBL] [Abstract][Full Text] [Related]
3. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
5. Pivotal Role of IL-22 Binding Protein in the Epithelial Autoregulation of Interleukin-22 Signaling in the Control of Skin Inflammation.
Fukaya T; Fukui T; Uto T; Takagi H; Nasu J; Miyanaga N; Arimura K; Nakamura T; Koseki H; Choijookhuu N; Hishikawa Y; Sato K
Front Immunol; 2018; 9():1418. PubMed ID: 29977242
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
7. Elevated IL-22 in psoriasis plays an anti-apoptotic role in keratinocytes through mediating Bcl-xL/Bax.
Wang B; Han D; Li F; Hou W; Wang L; Meng L; Mou K; Lu S; Zhu W; Zhou Y
Apoptosis; 2020 Oct; 25(9-10):663-673. PubMed ID: 32632545
[TBL] [Abstract][Full Text] [Related]
8. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
[TBL] [Abstract][Full Text] [Related]
9. Detection of IL-20 and its receptors on psoriatic skin.
Wei CC; Chen WY; Wang YC; Chen PJ; Lee JY; Wong TW; Chen WC; Wu JC; Chen GY; Chang MS; Lin YC
Clin Immunol; 2005 Oct; 117(1):65-72. PubMed ID: 16043414
[TBL] [Abstract][Full Text] [Related]
10. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
11. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
12. IL-20-Receptor Signaling Delimits IL-17 Production in Psoriatic Inflammation.
Ha HL; Wang H; Claudio E; Tang W; Siebenlist U
J Invest Dermatol; 2020 Jan; 140(1):143-151.e3. PubMed ID: 31252033
[TBL] [Abstract][Full Text] [Related]
13. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
14. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
15. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
16. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
17. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.
Tohyama M; Hanakawa Y; Shirakata Y; Dai X; Yang L; Hirakawa S; Tokumaru S; Okazaki H; Sayama K; Hashimoto K
Eur J Immunol; 2009 Oct; 39(10):2779-88. PubMed ID: 19731362
[TBL] [Abstract][Full Text] [Related]
18. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
20. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]